Trials / Completed
CompletedNCT00473915
Intranasal Steroids and the Nasal Ocular Response
Intranasal Steroids Prevent Antigen-Induced Hyperresponsiveness of the Nasal Ocular Response
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- University of Chicago · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Eye symptoms of tearing, redness and itch frequently occur in patients with allergic rhinitis or hayfever. The purpose of this study is to learn whether placing allergen (the substance that causes allergies) in the nose several days in a row will cause an increase in eye symptoms and whether receiving a nasal steroid spray will prevent these eye symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | fluticasone furoate | corticosteroid nasal spray |
Timeline
- Start date
- 2007-04-01
- Primary completion
- 2007-12-01
- Completion
- 2008-02-01
- First posted
- 2007-05-16
- Last updated
- 2013-06-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00473915. Inclusion in this directory is not an endorsement.